- Home
- SXTP vs PLRZ Comparison
SXTP vs PLRZ Comparison
Compare SXTP & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- PLRZ
- Stock Information
- Founded
- SXTP 2010
- PLRZ 2005
- Country
- SXTP United States
- PLRZ Israel
- Employees
- SXTP N/A
- PLRZ N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- PLRZ
- Sector
- SXTP Health Care
- PLRZ
- Exchange
- SXTP Nasdaq
- PLRZ NYSE
- Market Cap
- SXTP 2.4M
- PLRZ 2.3M
- IPO Year
- SXTP 2023
- PLRZ 2024
- Fundamental
- Price
- SXTP $1.88
- PLRZ $0.39
- Analyst Decision
- SXTP Hold
- PLRZ
- Analyst Count
- SXTP 1
- PLRZ 0
- Target Price
- SXTP N/A
- PLRZ N/A
- AVG Volume (30 Days)
- SXTP 31.9K
- PLRZ 648.7K
- Earning Date
- SXTP 05-14-2025
- PLRZ 02-15-2025
- Dividend Yield
- SXTP N/A
- PLRZ N/A
- EPS Growth
- SXTP N/A
- PLRZ N/A
- EPS
- SXTP N/A
- PLRZ N/A
- Revenue
- SXTP $681,345.00
- PLRZ N/A
- Revenue This Year
- SXTP $147.16
- PLRZ N/A
- Revenue Next Year
- SXTP $101.60
- PLRZ N/A
- P/E Ratio
- SXTP N/A
- PLRZ N/A
- Revenue Growth
- SXTP 168.70
- PLRZ N/A
- 52 Week Low
- SXTP $1.41
- PLRZ $0.28
- 52 Week High
- SXTP $36.00
- PLRZ $4.80
- Technical
- Relative Strength Index (RSI)
- SXTP 42.74
- PLRZ N/A
- Support Level
- SXTP $1.72
- PLRZ N/A
- Resistance Level
- SXTP $1.92
- PLRZ N/A
- Average True Range (ATR)
- SXTP 0.18
- PLRZ 0.00
- MACD
- SXTP 0.07
- PLRZ 0.00
- Stochastic Oscillator
- SXTP 39.29
- PLRZ 0.00
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.